# Saudi Arabia Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Saudi Arabia HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Saudi Arabia (SAU)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $563.9M
- Products: 39
- Buyer markets: 29
- Average CAGR: +31.8%
- Global sector size: $558.6B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $281.9B | $7.3M | $107.9B | -8.0% | 17 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $54.1B | $741.7K | $21.2B | +134.1% | 6 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $24.8B | $13.0M | $18.3B | +11.1% | 9 | +0.1% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $23.2B | $51.2K | $14.3B | -16.4% | 7 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $25.3B | $200.7K | $13.6B | +53.6% | 4 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $15.8B | $390.6 | $9.6B | +34.6% | 4 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $8.3B | $6.6 | $9.1B | -48.8% | 2 | +0.0% |
| HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $8.3B | $563.0K | $8.5B | +17.6% | 1 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $18.2B | $190.2K | $8.0B | +1.1% | 4 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $5.5B | $5.4K | $7.1B | +6.8% | 2 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $15.1B | $338.9K | $6.3B | +9.8% | 3 | +0.0% |
| HS 290110 - Acyclic hydrocarbons: saturated | $3.5B | $3.4M | $6.2B | +0.4% | 3 | +0.1% |
| HS 290243 - Cyclic hydrocarbons: p-xylene | $8.5B | $62.8M | $6.2B | +2.9% | 1 | +0.7% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $7.2B | $3.2K | $5.7B | +26.7% | 2 | +0.0% |
| HS 290919 - Ethers: acyclic, and their halogenated, sulphonated, nitrated or nitrosated derivatives, other than diethyl ether | $3.0B | $336.1K | $4.3B | -19.3% | 2 | +1.0% |
| HS 330300 - Perfumes and toilet waters | $6.6B | $7.9M | $4.0B | +4.8% | 2 | +0.1% |
| HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $4.5B | $16.0M | $3.8B | +3.8% | 2 | +0.3% |
| HS 290220 - Cyclic hydrocarbons: benzene | $4.1B | $18.8M | $3.4B | +23.9% | 1 | +0.5% |
| HS 281820 - Aluminium oxide: other than artificial corundum | $3.5B | $19.0M | $3.3B | -13.9% | 2 | +0.7% |
| HS 284410 - Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $2.8B | $36.8K | $2.6B | +36.4% | 2 | +0.0% |
| HS 290121 - Acyclic hydrocarbons: unsaturated, ethylene | $1.8B | $8.8M | $2.4B | +25.0% | 1 | +0.5% |
| HS 285390 - Phosphides, chemically defined or not, not ferrophosphorus: other inorganic compounds n.e.c. (including distilled, conductivity water and water of like purity): liquid air, rare gases removed or not: compressed air: amalgams, not precious metal amalgams | $1.3B | $432.6 | $2.4B | -12.7% | 1 | +0.0% |
| HS 310540 - Fertilizers, mineral or chemical: ammonium dihydrogenorthophosphate (monoammonium phosphate) and mixtures thereof with diammonium hydrogenorthophosphate (diammonium phosphate) | $3.9B | $399.7M | $2.3B | +30.1% | 2 | +7.4% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $191.0K | $2.0B | -8.6% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $194.1K | $1.9B | +25.7% | 1 | +0.0% |
| HS 290122 - Acyclic hydrocarbons: unsaturated, propene (propylene) | $1.6B | $2.7M | $1.8B | +23.5% | 1 | +0.2% |
| HS 370790 - Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $2.2B | $15.7K | $1.8B | +30.4% | 1 | +0.0% |
| HS 284420 - Uranium: enriched in U235, plutonium, their compounds, alloys dispersions (including cermets), ceramic products and mixtures containing uranium enriched in U235, plutonium or compounds of these products | $4.9B | $102.5K | $1.7B | +15.9% | 1 | +0.0% |
| HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $40.7 | $1.4B | -24.8% | 1 | +0.0% |
| HS 291736 - Acids: aromatic polycarboxylic acids: terephthalic acid and its salts | $1.6B | $93.5K | $1.4B | -15.5% | 1 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $524.0 | $1.4B | +24.5% | 1 | +0.0% |
| HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $2.8B | $1.4K | $1.3B | +8.9% | 1 | +0.0% |
| HS 382370 - Industrial fatty alcohols | $1.0B | $60.5K | $1.3B | -42.6% | 1 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $875.7M | $8.1K | $1.3B | -2.6% | 1 | +0.0% |
| HS 310221 - Fertilizers, mineral or chemical: nitrogenous, ammonium sulphate | $965.4M | $488.5K | $1.3B | +1765.8% | 1 | +0.7% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $1.8B | $3.3K | $1.2B | -21.5% | 1 | +0.0% |
| HS 310559 - Fertilizers, mineral or chemical: containing the two fertilizing elements nitrogen and phosphorus, other than nitrates and phosphates | $581.7M | $956.2K | $1.1B | +146.3% | 1 | +0.2% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $11.8K | $1.1B | -4.7% | 1 | +0.0% |
| HS 290250 - Cyclic hydrocarbons: styrene | $768.8M | $6.4K | $1.1B | -19.3% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $59.8B calculated opportunity across 14 products.
- China (CHN): $39.4B calculated opportunity across 14 products.
- Switzerland, Liechtenstein (CHE): $37.8B calculated opportunity across 5 products.
- Germany (DEU): $24.3B calculated opportunity across 7 products.
- Belgium (BEL): $21.6B calculated opportunity across 5 products.
- Netherlands (NLD): $17.9B calculated opportunity across 5 products.
- United Kingdom (GBR): $10.7B calculated opportunity across 5 products.
- Canada (CAN): $10.4B calculated opportunity across 6 products.
- Slovenia (SVN): $9.7B calculated opportunity across 1 products.
- France (FRA): $8.2B calculated opportunity across 4 products.
- Spain (ESP): $7.7B calculated opportunity across 3 products.
- Mexico (MEX): $7.0B calculated opportunity across 4 products.

## Growth stars

- HS 310221: +1765.8% average CAGR, $1.3B calculated opportunity.
- HS 310559: +146.3% average CAGR, $1.1B calculated opportunity.
- HS 300215: +134.1% average CAGR, $21.2B calculated opportunity.
- HS 300212: +53.6% average CAGR, $13.6B calculated opportunity.
- HS 284410: +36.4% average CAGR, $2.6B calculated opportunity.
- HS 300214: +34.6% average CAGR, $9.6B calculated opportunity.
- HS 370790: +30.4% average CAGR, $1.8B calculated opportunity.
- HS 310540: +30.1% average CAGR, $2.3B calculated opportunity.
- HS 293499: +26.7% average CAGR, $5.7B calculated opportunity.
- HS 382319: +25.7% average CAGR, $1.9B calculated opportunity.

## Diversification opportunities

- HS 300490: 17 buyer markets, $107.9B calculated opportunity.
- HS 382499: 9 buyer markets, $18.3B calculated opportunity.
- HS 300439: 7 buyer markets, $14.3B calculated opportunity.
- HS 300215: 6 buyer markets, $21.2B calculated opportunity.
- HS 300212: 4 buyer markets, $13.6B calculated opportunity.
- HS 300214: 4 buyer markets, $9.6B calculated opportunity.
- HS 330499: 4 buyer markets, $8.0B calculated opportunity.
- HS 382200: 3 buyer markets, $6.3B calculated opportunity.
- HS 290110: 3 buyer markets, $6.2B calculated opportunity.
- HS 300220: 2 buyer markets, $9.1B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.